By 
A pharmacist dilutes the Pfizer COVID-19 vaccine while preparing it to administer to staff and residents at the Goodwin House Bailey’s Crossroads, a senior living community in Falls Church, Virginia, on December 30, 2020.
Brendan Smialowski | AFP | Getty Images
LONDON — Health experts have conditionally backed the U.K.’s decision to delay administering a second dose of the coronavirus vaccine developed by Pfizer and BioNTech, warning that the need to suppress the new coronavirus strain “cannot be overstated.”
It comes shortly after the U.K. said second doses of the Pfizer-BioNTech jab, in addition to the newly-approved Covid-19 vaccine developed by AstraZeneca and the University of…
Source cnbc.com
Leave a Reply